TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 4 | 5 | 3 | 11 | -14 | -18 | -28 | -7 |
| P | %wins | 100 | 75 | 75 | 25 | 25 | 25 | 54 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/2/06 16:13 | 9/28/06 | CVM | Cel Sci Corp | CO | Health | BioPrd | Biological Products, (No Diag | Talor Eyal | VA | O | SVP | P | 12 | 0.5800 | 0 | 21 | 5 | 460 | D | 9 | 35 | -15 | -28 | 3 | 7 | 2 | -2 | 8 | 8 | 16 | -8 | 19 | 3 |
7/2/04 09:36 | 6/30/04 | CVM | Cel Sci Corp | CO | Health | BioPrd | Biological Products, (No Diag | Talor Eyal | VA | O | SVP | P | 1 | 0.7400 | 0 | 2 | 0 | 398 | D | 175 | -1 | -28 | -34 | -16 | -10 | -3 | -1 | 0 | -13 | 0 | -26 | -18 | -32 |
4/1/04 17:13 | 4/1/04 | CVM | Cel Sci Corp | CO | Health | BioPrd | Biological Products, (No Diag | Talor Eyal | VA | O | SVP | P | 1 | 1.13 | 0 | 1 | 0 | 397 | D | 119 | 427 | 25 | 8 | -3 | 4 | 12 | 30 | 3 | 3 | -4 | -30 | -47 | -43 |
12/31/03 18:34 | 12/31/03 | CVM | Cel Sci Corp | CO | Health | BioPrd | Biological Products, (No Diag | Talor Eyal | VA | O | SVP | P | 1 | 1.05 | 0 | 1 | 0 | 396 | D | 14 | 410 | 37 | 15 | -16 | -12 | -2 | -2 | 8 | 13 | 30 | 9 | -27 | -40 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |